Sun Pharmaceuticals Industries Ltd Nine Monthly Results

1,804.85
(-0.47%)
Dec 6, 2024|03:31:07 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Dec-2023Dec-2022Dec-2021Dec-2020Dec-2019

Gross Sales

35,945.12

32,553.3

29,040.34

24,769.34

24,247.14

Excise Duty

0

0

0

0

0

Net Sales

35,945.12

32,553.3

29,040.34

24,769.34

24,247.14

Other Operating Income

568.83

401.71

167.39

205.82

405.42

Other Income

748.25

261.24

807.92

1,012.8

533.75

Total Income

37,262.2

33,216.25

30,015.65

25,987.96

25,186.31

Total Expenditure

26,918.65

24,110.35

21,781.45

22,165.56

19,025.81

PBIDT

10,343.55

9,105.9

8,234.2

3,822.4

6,160.5

Interest

164.9

79.26

90.01

111.33

250.95

PBDT

10,178.65

9,026.64

8,144.19

3,711.07

5,909.55

Depreciation

1,906.28

1,857.9

1,587.27

1,526.46

1,477.4

Minority Interest Before NP

0

0

0

0

0

Tax

1,290.52

624.68

928.74

747.93

739.71

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

6,981.85

6,544.06

5,628.18

1,436.68

3,692.44

Minority Interest After NP

29.49

40.93

66.68

-579.73

314.11

Net Profit after Minority Interest

6,921.8

6,489.11

5,549.98

2,009.67

3,365.09

Extra-ordinary Items

-331.42

0

-541.68

-1,912.03

0

Adjusted Profit After Extra-ordinary item

7,253.22

6,489.11

6,091.66

3,921.7

3,365.09

EPS (Unit Curr.)

28.8

27

23.1

8.38

14.03

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

850

750

700

550

300

Equity

239.93

239.93

239.93

239.93

239.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.77

27.97

28.35

15.43

25.4

PBDTM(%)

28.31

27.72

28.04

14.98

24.37

PATM(%)

19.42

20.1

19.38

5.8

15.22

Sun Pharma.Inds.: Related NEWS

Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Sun Pharma's Hair Loss Drug Approved by USFDA
26 Jul 2024|01:45 PM

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Read More
Mayne Pharma Sues Sun Pharma in Patent Dispute
25 Jul 2024|11:57 AM

IMVEXXY is a vaginal insert designed to lessen pain during sexual activity after menopause which is manufactured by Mayne Pharma.

Read More
USFDA grills Sun Pharma for manufacturing issues at Dadra facility
4 Jul 2024|11:24 AM

The warning letter detailed substantial violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp